LB 71116

Drug Profile

LB 71116

Alternative Names: LK 71116

Latest Information Update: 22 Aug 2007

Price : $50

At a glance

  • Originator LG Chem Investment
  • Class Antivirals; Oligopeptides
  • Mechanism of Action HIV protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 13 May 2003 No development reported - Preclinical for HIV-1 infections in South Korea (unspecified route)
  • 07 Jun 2001 Preclinical development for HIV-1 infections in South Korea (Unknown route)
  • 02 Sep 1998 No-Development-Reported for HIV-1 infections in South Korea (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top